Centre Orders Strict Monitoring of Reduced Prices for 137 Anti-Cancer Drugs Across India
NEW DELHI, November 14: The Centre has directed state drug regulators to intensify monitoring of revised prices of 137 anti-cancer medicines, seeking to ensure that patients receive the full benefit of recently announced reductions in medicine costs.
The National Pharmaceutical Pricing Authority (NPPA), functioning under the Department of…
Read More...